Form 4: Medtronic Director Kendall J. Powell Reports Stock Transactions

Kendall J. Powell, a director at Medtronic, reported the acquisition of shares through restricted stock units and the withholding of shares for tax obligations.

Summary

• On April 28, 2025, Medtronic director Kendall J. Powell acquired 2,083 ordinary shares at a price of $84.04 through restricted stock units.
• These restricted stock units vest on the one-year anniversary of the award date.
• Powell also acquired 912 shares through dividend reinvestment since the last report.
• On April 29, 2025, 216 shares were withheld for payment of taxes upon the vesting of restricted stock units at a price of $84.6.
• Following these transactions, Powell beneficially owns 48,622 ordinary shares.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions by a company director, with no inherent positive or negative implications for the company's overall performance.

Positives

• The acquisition of shares through restricted stock units and dividend reinvestment increases Powell's stake in Medtronic, potentially aligning his interests with those of other shareholders.

Negatives

• The withholding of shares for tax obligations reduces the net increase in Powell's holdings.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It is a standard practice for directors and officers of publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for directors and officers of publicly traded companies like Medtronic, similar to filings made by insiders at companies such as Johnson & Johnson, Abbott Laboratories, and Boston Scientific.
• The reporting requirements are consistent across the industry, ensuring transparency in insider trading activities.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly increasing the director's alignment with shareholder interests.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Medtronic, Director, Kendall J. Powell, Stock Transactions, Form 4, Restricted Stock Units, Dividend Reinvestment, Beneficial Ownership, SEC Filing